Identification of 5-hydroxymethylfurfural in cigarette smoke extract as a new substrate metabolically activated by human cytochrome P450 2A13

Toxicol Appl Pharmacol. 2018 Nov 15:359:108-117. doi: 10.1016/j.taap.2018.09.031. Epub 2018 Sep 22.

Abstract

Cytochrome P450 2A13 (CYP2A13) is an extrahepatic enzyme mainly expressed in the human respiratory system and is reported to mediate tobacco-specific N-nitrosamines (TSNA) metabolism in cigarette smoke. This study aimed to identify other new substrates of CYP2A13 in cigarette smoke and their corresponding respiratory toxicity. Following separation by HPLC, GC-MS/MS, NMR and cytotoxicity assays in BEAS-2B cells stably expressing CYP2A13 (B-2A13), 5-Hydroxymethylfurfural (5-HMF) was screened and identified in the 4-5 min section of cigarette smoke extract (CSE). In vitro metabolism results showed that CYP2A13 mediated the fast clearance of 5-HMF and formed the metabolite 5-HMF acid (5-HMFA). CSE 5-HMF (CSE-5-HMF) showed cytotoxicity similar to that of standard 5-HMF in B-2A13 and B-2A5 cells, which was inhibited by 8-methoxypsoralen (8-MOP), a CYP enzyme inhibitor. Mouse CYP2A5, a homologous CYP enzyme to CYP2A13, shares many substrates with CYP2A13 in cigarette smoke. Thus, CYP2A5-/- mice were generated to explore the role of CYP2A5 in 5-HMF bioactivation. Compared with CYP2A5-/- mice, WT mice showed serious histological lung and nasal olfactory mucosa damage, as well as increased inflammatory cells and elevated TNF-α and IL-6 levels in bronchoalveolar lavage fluid. Besides, nasal microsomes undertook fast 5-HMFA formation in WT mice than that in CYP2A5-/- mice, which could be inhibited by 8-MOP. This study is the first to identify 5-HMF as a new toxic substrate of human CYP2A13 in cigarette smoke, it may play a potential role in cigarette smoke-induced respiratory injuries.

Keywords: 5-hydroxymethylfurfural; Cigarette smoke extract; Cytochrome P450 2A13; Metabolic activation; Respiratory injuries.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activation, Metabolic
  • Animals
  • Aryl Hydrocarbon Hydroxylases / antagonists & inhibitors
  • Aryl Hydrocarbon Hydroxylases / metabolism*
  • Bronchoalveolar Lavage Fluid / chemistry
  • Cell Line
  • Enzyme Inhibitors / pharmacology
  • Furaldehyde / analogs & derivatives*
  • Furaldehyde / analysis
  • Furaldehyde / pharmacology
  • Humans
  • Interleukin-6 / biosynthesis
  • Interleukin-6 / genetics
  • Male
  • Mice
  • Mice, Knockout
  • Microsomes / enzymology
  • Microsomes / metabolism
  • Respiratory Mucosa / drug effects
  • Respiratory Mucosa / pathology
  • Smoke / analysis*
  • Tobacco Products / analysis*
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Enzyme Inhibitors
  • Interleukin-6
  • Smoke
  • Tumor Necrosis Factor-alpha
  • interleukin-6, mouse
  • 5-hydroxymethylfurfural
  • Furaldehyde
  • Aryl Hydrocarbon Hydroxylases
  • CYP2A13 protein, human